Prelude Therapeutics Inc

PRLD · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.4B · 79 employees
107
SEC Filings
$3.875
Close 2026-09-25
79
Employees

Business Summary

Prelude Therapeutics Incorporated is a precision oncology company focused on drug discovery and development of novel cancer medicines. The company develops kinase inhibitors, targeted protein degraders, and antibody-drug conjugates. Key programs include PRT12396, a mutant-selective JAK2V617F inhibitor for myeloproliferative neoplasms, and a KAT6A selective degrader for ER+ breast cancer. Prelude has partnered with Incyte Corporation on JAK2V617F and with AbCellera Biologics on degrader-payload antibody programs.

Latest Stock Quote

PRLD 2026-09-25 $3.875 O:$4 H:$4.05 L:$3.83 Vol:0.3M VWAP:$3.8812
origin leaf: null

Next Earnings

Q2 FY2026 — expected 2026-09-13

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-102025-12-310001193125-26-099428EDGAR84K words
2025-03-102024-12-310000950170-25-035921EDGAR83K words
2024-02-152023-12-310000950170-24-016016EDGAR79K words
2023-03-152022-12-310000950170-23-007989EDGAR—
2022-03-172021-12-310001564590-22-010723EDGAR—
2021-03-162020-12-310001564590-21-013330EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-112026-06-300001193125-26-343475EDGAR20K words
2025-11-122025-09-300001193125-25-275887EDGAR21K words
2025-08-142025-06-300000950170-25-108417EDGAR20K words
2025-05-062025-03-310000950170-25-064566EDGAR18K words
2024-11-062024-09-300000950170-24-122377EDGAR22K words
2024-08-122024-06-300000950170-24-095065EDGAR21K words
2024-05-072024-03-310000950170-24-053940EDGAR17K words
2023-11-012023-09-300000950170-23-057523EDGAR19K words
2023-08-032023-06-300000950170-23-037611EDGAR18K words
2023-05-082023-03-310000950170-23-018478EDGAR—
2022-11-142022-09-300000950170-22-024732EDGAR—
2022-08-092022-06-300001564590-22-028596EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-100001193125-26-387232EDGAR4K words
2026-08-110001193125-26-343469EDGAR3K words
2026-03-120001193125-26-104204EDGAR1K words
2026-03-100001193125-26-099424EDGAR3K words
2026-02-030001193125-26-034564EDGAR1K words
2026-01-090001193125-26-008280EDGAR3K words
2025-11-120001193125-25-275871EDGAR3K words
2025-11-040000929638-25-004115EDGAR2K words
2025-10-170001193125-25-241968EDGAR1K words
2025-09-190001193125-25-208187EDGAR1K words

107 total filings indexed. 79 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

myeloproliferative-neoplasms-(mpns) er+-breast-cancer hematological-malignancies solid-tumors precision-oncology

Company Identity

CIK0001678660
TickerPRLD
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.preludetx.com
Listed2020-09-25

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: ef70a28b541b90a2004b0bae3b055f156a636d722c94df7430527cdd7da4a1bc
parent: 3e2ec4543aaff244f15b196c9ca01d54d2e260bf6ef98813d0fe34cce1fa55ea
content hash: 1efd9a769f5d12ea373b7ec028df6822a0832b6d207e01ff0c70ef9e5f17b2be
signed: 2026-09-28T19:02:42.023Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up PRLD using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on PRLD, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/PRLD (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.